RRvent ϭ ventilatory respiratory rate; RRpes ϭ esophageal respiratory rate; VAS ϭ visual analog scale; V co 2 ϭ CO 2 production; V e ϭ minute ventilation; V eh ϭ minute ventilation delivered to the helmet; V ewh ϭ minute ventilation washing the helmet; Vt ϭ tidal volume
N
oninvasive ventilation (NIV) reduces the need for endotracheal intubation, [1] [2] [3] [4] [5] decreases the frequency of infections, 6 -7 and may improve the survival rate of patients with acute respiratory failure. [1] [2] [3] [4] [5] A considerable effort has been made in the last 5 years to improve devices and tolerance. 8 -12 The choice of the interface is one of the crucial issues affecting NIV outcome. [11] [12] New interfaces have been introduced with the aim of improving patient comfort. The helmet is one of the newest interfaces that can reduce several side effects of NIV-skin necrosis, conjunctivitis, eyes irritation, and gastric distension [13] [14] [15] -and improve tolerance in both adult and pediatric patients. 16 Despite these advantages, the helmet has specific drawbacks, primarily related to its large volume 14 and to its highly compliant soft collar. 17 Inspiratory pressure dissipation may increase the time lag between inspiratory effort and ventilatory assistance, with a further impairment of ventilator functioning. 17 Moreover, due to its large volume, a certain amount of CO 2 rebreathing may be present. Some authors have proposed that during continuous positive airway pressure (CPAP), CO 2 rebreathing depends on interface volume, CO 2 production (V co 2 ), 18 and the flow of gases flushing through the helmet. 18, 19 It has been recently demonstrated that in normal subjects receiving NIV, the CO 2 concentration was slightly higher with the helmet than with the mask. 14 However, most studies analyzed helmet effects only during CPAP, 18, 19 or by applying a single level of pressure support (PS) and positive end-expiratory pressure (PEEP), 14, 17 while the effects of incremental PS and PEEP both on pressurization time and CO 2 rebreathing were never investigated. The aim of the present physiologic study was to evaluate breathing pattern, inspiratory effort, CO 2 rebreathing, and comfort in healthy volunteers receiving NIV with a helmet at various levels of PS and PEEP.
Materials and Methods
The protocol was approved by our institutional review board, and written informed consent was obtained from each subject. NIV was delivered through a helmet equipped with an soft inner inflatable cushion for dead space reduction (CaStar Starmed; Starmed; Mirandola, Italy) [Fig 1] using an ICU ventilator (EVITA 4; Dräger Medical; Lü beck, Germany) set in PS ventilation (PSV) mode. The fraction of inspired oxygen was set at 0.21, and the inspiratory trigger threshold was set at 2 L/min, checking the absence of the autotriggering phenomena.
Study Protocol
We studied eight white, healthy volunteers, naïve to NIV, in a semirecumbent position and in a quiet environment. The subjects (two women and six men; age range, 24 to 28 years; mean, 25.38 Ϯ 1.30 years [Ϯ SD]) were all nonsmokers and had a body mass index ranging from 18 to 24.6 kg/m 2 (mean, 22.9 Ϯ 2.9 kg/m 2 ). Before initiating the study, a latex balloon-tipped catheter was placed in the middle third of the esophagus, and its proper positioning was checked by an occlusion test. 20 After 20 min of spontaneous unassisted breathing, all of the subjects underwent five NIV trials (20- 
Equipment
The airflow delivered by the ventilator to the helmet during the inspiratory phase was measured with a pneumotachograph (Fleisch No. 2; Metabo; Epalinges, Switzerland) positioned at the distal end of the inspiratory limb of the circuit (Fig 2) . The airway pressure at the inspiratory limb of the circuit was measured by a pressure transducer with a differential pressure of Ϯ 1 cm H 2 O (Digima Clic-1, ICU-Lab System; KleisTEK Engineering; Bari, Italy) placed distally to the pneumotachograph. Esophageal pressure (Pes) was measured by an esophageal catheter connected to a pressure transducer (Digima Clic-1, ICU-Lab System; KleisTEK Engineering). The signals were amplified, lowpass filtered, digitized at 100 Hz, and stored in a personal computer for further analysis. The last 5 min of each trial were averaged and used for further data analysis (ICU Lab 2.1; KleisTEK Engineering).
The airflow at the mouth and the partial pressure of inspired CO 2 (Pico 2 ) were measured at the airway opening using a small mouthpiece, including a flow and a capnographic sensor (CO 2 SMO Plus model 8100; Novametrix Medical Systems; Wallingford, CT). This device was positioned under the helmet soft collar, before initiating the study, and held in the mouth by the subjects during the last 5 min of each trial. The presence of air leaks was carefully avoided by sealing the collar to the neck with Parafilm (Pechiney Plastic Packaging; Neenah, WI). The obtained measurements were analyzed by dedicated software (Analysis Plus; Novametrix Medical Systems). The tidal volume (Vt) at the mouth was calculated integrating the airflow at the mouth over time. In addition, we measured the mean partial pressure of expired CO 2 (Peco 2 ) from a 2-L reservoir bag placed proximal to the expiratory port of the ventilator, at the end of the expiratory limb of the circuit, by means of a three-way connector (Fig 1) . At the distal end of the reservoir bag, a stopcock was mounted to sample, after 20-h equilibration, the exhaled gases for measurements of the Pco 2 into the system (Stat-profile Ultra; NovoBiomedical; Waltham, MA).
The esophageal respiratory rate (RRpes) and the number of 21 PTP per minute was calculated by multiplying esophageal PTP per breath and RRpes, while PTP per liter was defined as the ratio between PTP per minute and V e. The inspiratory delay was calculated as the time lag between the beginning of the inspiratory effort and ventilator assistance, while the pressurization time was defined as the time necessary to achieve the preset level of PS. The difference between the minute ventilation (V e) delivered to the helmet (V eh) [measured on the inspiratory limb of the helmet] and subject V e (measured at the airway opening) represented the V e washing the helmet (V ewh). V co 2 was determined automatically by the Novametrix system according to the following equation: 18 -22 To evaluate comfort during NIV, we administered at the end of each trial a visual analog scale (VAS), where 0 indicated the best comfort and 10 indicated the worst comfort.
Statistical Analysis
Data are expressed as mean Ϯ SD. The analysis of variance for repeated measures was used to detect significant differences between the different experimental conditions. When significant differences were detected, post hoc analysis was performed using the Tukey test; p Յ 0.05 was considered significant.
Results
All the subjects completed the study protocol. In comparison to spontaneous breathing, during helmet Table 1 ].
No significant differences were found between RRvent and RRpes, which were similar during the whole study period (Table 1 ). In comparison with unassisted breathing, with increasing levels of assistance, we observed an increase in Vt mea- Table 1 ]. Subject V e did not significantly change during the whole study period, as shown in Table 1 .
Data related to inspiratory effort are shown in Table 2 The analysis of patient/ventilator interaction showed the absence of wasted efforts and autocycling phenomena over the study period. Increased levels of assistance did not affect the inspiratory delay and the pressurization time ( Table 2 ).
The analysis of CO 2 rebreathing did not show a significant reduction in Pico 2 nor a significant modification in end-tidal CO 2 by increasing the level of assistance (Fig 3) , and the different levels of PS did not significantly change the V co 2 as well. Incremental levels of PS from 5 to 10 cm H 2 O decreased Peco 2 from 10.48 Ϯ 1.34 to 8.73 Ϯ 1.47 mm Hg (p Ͻ 0.05), while a further increase in the level of assistance did not produce other changes ( Table 1) . As shown in Figure 4 , V ewh significantly increased when the level of assistance was increased from 5 to 10 cm H 2 O (p ϭ 0.0087). Interestingly, the reduction in the helmet dead space by inflating the cushion or by increasing helmet pressurization (high PEEP) reduced V ewh despite constant values of subject V e.
All subjects were asked to evaluate the comfort using a VAS from 0 (best comfort) to 10 (worst comfort) at the end of each trial. Our results showed that a low level of PS (5 to 
Discussion
The main finding of the present study is that increasing levels of assistance in healthy volunteers receiving PS ventilation through a helmet signifi- cantly reduced RRpes, with a significant increase in Vt. Increasing levels of assistance produced a significant reduction in tidal excursions of Pes only during PS/PEEP at 10/5 cm H 2 O with the cushion inflated and PS/PEEP at 10/10 cm H 2 O, while, compared to spontaneous breathing, ventilatory support produced a significant decrease of PTP per liter regardless of the PS/PEEP combination applied. NIV delivered through a helmet has been shown to be an interesting alternative to the conventional facemask, increasing patient tolerance and reducing the most common side effects of the mask. 6 -9 Despite the good efficiency and tolerability, 6 -9 the use of the helmet is still controversial. This is mainly related to the increased dead space 14 and the occurrence of patient/ventilator asynchrony. 14, 17 In a study comparing helmet CPAP and mask CPAP, Patroniti and colleagues 19 found that both interfaces were effective in increasing the endexpiratory lung volume, but high gas flows (40 to 60 L/min) were required with the helmet to maintain a low Pico 2 . Taccone and colleagues 18 obtained similar results, finding that CO 2 rebreathing during helmet CPAP was related to V co 2 production and fresh gas flows. In that study, 18 the authors recommended avoiding the use of the helmet with ventilator CPAP, showing that only a continuous high gas flow made CO 2 rebreathing clinically irrelevant. Recently, Chiumello and colleagues 17 compared the helmet to the mask in a group of healthy subjects receiving free-flow CPAP and a fixed level of PS/ PEEP. Their results showed that both interfaces reduced the work of breathing in comparison to spontaneous breathing, but during PS the mask was more efficient than the helmet 17 ; these authors hypothesized that the pressure delivered by the ventilator was partially spent to pressurize the large inner volume of the helmet, interfering with patient/ machine interaction, with a lower level of assistance in the initial phase of the breathing effort.
Different from studies that evaluated the helmet efficacy during free-flow CPAP or PSV with a single level of PS and PEEP, we investigated the effects of different levels of PS and PEEP on inspiratory effort, patient/ventilator interaction, CO 2 rebreathing, and comfort. In order to eliminate any possible bias, all of our healthy individuals never experienced the helmet or PSV before the study. The slight reduction in tidal excursions of Pes that we observed can probably be explained by the normal respiratory drive, respiratory muscle function, and respiratory mechanics of our volunteers, for whom high levels of assistance were probably excessive and poorly tolerated, as demonstrated by the VAS analysis. High levels of PS, more than high levels of PEEP, were considered by the volunteers to be "uncomfortable and difficult to overwhelm." Despite the high degree of discomfort, all of the volunteers kept synchrony with the ventilator, as shown by the inspiratory delay that did not significantly change for the whole course of the study, as well as by the absence of wasted efforts or autocycling phenomena.
A possible explanation is that the subjects maintained synchrony with the ventilator by increasing inspiratory and probably expiratory efforts at increasing levels of assistance. Consequently, their respiratory muscles were less unloaded and this produced a net increase in subject discomfort.
The increase of PS levels did not change Pico 2 , end-tidal CO 2 , and V co 2 during the study. A slight but significant Peco 2 decrease was observed only with PS/PEEP at 10/5 cm H 2 O.
In the present study, Pico 2 values were similar to those observed by Taccone et al 18 and Patroniti et al, 19 who used CPAP with flow rates from 30 to 60 L/min. In our study, V eh delivered to the system was lower (Ͻ 40 L/min) and V ewh was from 13 to 27 L/min. This more efficient CO 2 washout is probably related to the phasic administration of inspiratory flow during PSV.
Different from our expectations, helmet pressurization produced by inflating the cushion or increasing the PEEP level caused a decrease in V ewh, despite the significant reduction in inspiratory effort, seriously questioning its clinical utility. Finally, the helmet was well tolerated with 5 cm H 2 O and 10 cm H 2 O of PS, and a significant discomfort was observed only with PS at 15 cm H 2 O.
In conclusion, our study demonstrates that the helmet is effective in reducing the inspiratory effort and is efficient in providing ventilation to healthy volunteers, without relevant CO 2 rebreathing. It is worth remembering that the results of the present study were achieved in healthy volunteers. The generalization of the present data to patients with acute respiratory failure remains to be proven.
